A mechanistic rationale for incretin-based therapeutics in the management of obesity
FDA-approved GLP-1 receptor agonists (including semaglutide, dulaglutide, liraglutide, and others) are indicated for adults with type 2 diabetes as adjuncts to diet and exercise to improve glycemic control
GLP-1 for PCOS: The App for Weight, Meals, and Symptoms MeAgain is the best GLP-1 for PCOS app because it keeps meals, hydration, symptoms, weight, and the weekly shot in one readable timeline
Weight loss achieved through GLP-1 therapy contributes significantly to improved lipid profiles, as adipose tissue reduction typically correlates with favourable changes in cholesterol levels
GLP-1 and the neurobiology of eating control: Recent advances
These effects combine to improve health